Cargando…
Mesenchymal stem cells in the treatment of osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a disease caused by mutations in different genes resulting in mild, severe, or lethal forms. With no cure, researchers have investigated the use of cell therapy to correct the underlying molecular defects of OI. Mesenchymal stem cells (MSCs) are of particular interest...
Autores principales: | Lang, Erica, Semon, Julie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892307/ https://www.ncbi.nlm.nih.gov/pubmed/36725748 http://dx.doi.org/10.1186/s13619-022-00146-3 |
Ejemplares similares
-
Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta
por: Chan, Jerry K. Y., et al.
Publicado: (2014) -
Osteogenesis Imperfecta
por: Sam, Justin Easow, et al.
Publicado: (2017) -
Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta
por: Götherström, Cecilia, et al.
Publicado: (2020) -
Radiographic features of osteogenesis imperfecta
por: Renaud, Armelle, et al.
Publicado: (2013) -
Trophic effects of multiple administration of mesenchymal stem cells in children with osteogenesis imperfecta
por: Ramesh, Sowmya, et al.
Publicado: (2021)